The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Drug-Permeability and Transporter Assays in Caco-2 and Mdck Cell Lines
Abstract
The human colon adenocarcinoma Caco-2 and Madin-Darby canine kidney epithelial cell lines provide in vitro tools to assess a drug's permeability and transporter interactions during discovery and development. The cells, when cultured on semiporous filters, form confluent monolayers that model the intestinal epithelial barrier for permeability, transporter and drug-interaction assays. The applications of these assays in pharmaceutical research include qualitative prediction and ranking of absorption, determining mechanism(s) of permeability, formulation effects on drug permeability, and the potential for transporter-mediated drug-drug interactions. This review focuses on recent examples of Caco-2 and Madin-Darby canine kidney cells assays for drug permeability including transfected and knock-down cells, miniaturization and automation, and assay combinations to better understand and predict intestinal drug absorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80072-1 · Cited by 2,396
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803205 · Cited by 980
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling
Huang, S.-M., Temple, R., Throckmorton, D. C., & Lesko, L. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100054 · Cited by 579
Sun, D., Lennernas, H., Welage, L. S., Barnett, J. L., Landowski, C. P., Foster, D., Fleisher, D., Lee, K.-D., & Amidon, G. L. (2002) · Pharmaceutical Research · doi:10.1023/a:1020483911355 · Cited by 447
Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening
Yeh, T.-H., Hsu, L.-W., Tseng, M. T., Lee, P.-L., Sonjae, K., Ho, Y.-C., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.056 · Cited by 379
Englund, G., Rorsman, F., Rönnblom, A., Karlbom, U., Lazorova, L., Gråsjö, J., Kindmark, A., & Artursson, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.010 · Cited by 368
Intestinal permeability and its relevance for absorption and elimination
Lennernäs, H. (2007) · Xenobiotica · doi:10.1080/00498250701704819 · Cited by 304
Gertz, M., Harrison, A., Houston, J. B., & Galetin, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032649 · Cited by 297
Fenner, K., Troutman, M., Kempshall, S., Cook, J., Ware, J., Smith, D., & Lee, C. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.195 · Cited by 272
Hayeshi, R., Hilgendorf, C., Artursson, P., Augustijns, P., Brodin, B., Dehertogh, P., Fisher, K., Fossati, L., Hovenkamp, E., Korjamo, T., et al. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.08.004 · Cited by 263
Rautio, J., Humphreys, J. E., Webster, L. O., Balakrishnan, A., Keogh, J. P., Kunta, J. R., Serabjit-Singh, C. J., & Polli, J. W. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008615 · Cited by 260
Current industrial practices of assessing permeability and P-glycoprotein interaction
Balimane, P. V., Han, Y.-H., & Chong, S. (2006) · The AAPS Journal · doi:10.1208/aapsj080101 · Cited by 258
Variability in Caco-2 and MDCK Cell-Based Intestinal Permeability Assays
Volpe, D. A. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21010 · Cited by 252
Self-citationAre MDCK Cells Transfected with the Human MDR1 Gene a Good Model of the Human Intestinal Mucosa?
Tang, F., Horie, K., & Borchardt, R. T. (2002) · Pharmaceutical Research · doi:10.1023/a:1016140429238 · Cited by 213
Seithel, A., Karlsson, J., Hilgendorf, C., Björquist, A., & Ungell, A.-L. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.03.003 · Cited by 200
A regulatory viewpoint on transporter-based drug interactions
Zhang, L., Zhang, Y. (. )., Strong, J. M., Reynolds, K. S., & Huang, S.-M. (2008) · Xenobiotica · doi:10.1080/00498250802017715 · Cited by 188
Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability
(2008) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527623860 · Cited by 185
Analysis of drug transporter expression in human intestinal Caco‐2 cells by real‐time PCR
Maubon, N., Le Vee, M., Fossati, L., Audry, M., Le Ferrec, E., Bolze, S., & Fardel, O. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00550.x · Cited by 182
Sai, Y., Kaneko, Y., Ito, S., Mitsuoka, K., Kato, Y., Tamai, I., Artursson, P., & Tsuji, A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009530 · Cited by 168
Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
Bimbo, L. M., Mäkilä, E., Laaksonen, T., Lehto, V.-P., Salonen, J., Hirvonen, J., & Santos, H. A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.011 · Cited by 161
Towards Prediction of In Vivo Intestinal Absorption Using a 96-Well Caco-2 Assay
Skolnik, S. M., Lin, X., Wang, J., Chen, X.-H., He, T., & Zhang, B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22080 · Cited by 159
Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1
Annaert, P., Ye, Z., Stieger, B., & Augustijns, P. (2010) · Xenobiotica · doi:10.3109/00498250903509375 · Cited by 157
pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers
Neuhoff, S., Ungell, A.-L. B., Zamora, I., & Artursson, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.02.009 · Cited by 155
Troutman, M. D., & Thakker, D. R. (2003) · Pharmaceutical Research · doi:10.1023/a:1025049014674 · Cited by 154
Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Lineshape Analysis
Peters, S. A. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847040-00004 · Cited by 150
Elsby, R., Surry, D. D., Smith, V., & Gray, A. J. (2008) · Xenobiotica · doi:10.1080/00498250802050880 · Cited by 144
Application of Method Suitability for Drug Permeability Classification
Volpe, D. A. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9227-8 · Cited by 124
Self-citationRole of P-Glycoprotein Inhibition for Drug Interactions
Eberl, S., Renner, B., Neubert, A. C., Reisig, M., Bachmakov, I., König, J., Dörje, F., Mürdter, T. E., Ackermann, A., Dormann, H., et al. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746120-00004 · Cited by 120
Keogh, J. P., & Kunta, J. R. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.011 · Cited by 113
The biological and clinical role of drug transporters at the intestinal barrier
Oostendorp, R. L., Beijnen, J. H., & Schellens, J. H. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.09.004 · Cited by 113
Kuteykin‐Teplyakov, K. B., Luna‐Tortós, C., Ambroziak, K., & Löscher, W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00801.x · Cited by 110
Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin Drugs
Li, J., Volpe, D. A., Wang, Y., Zhang, W., Bode, C., Owen, A. J., & Hidalgo, I. J. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038075 · Cited by 101
Self-citationBiopharmaceutics Classification System: Validation and Learnings of an in Vitro Permeability Assay
Thiel-Demby, V. E., Humphreys, J. E., Williams, L. A. S. J., Ellens, H. M., Shah, N., Ayrton, A. D., & Polli, J. W. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800122b · Cited by 98
Shu, Y., Bello, C. L., Mangravite, L. M., Feng, B., & Giacomini, K. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29342-3 · Cited by 96
Classification of Drug Permeability with a Caco-2 Cell Monolayer Assay
Volpe, D. A., Faustino, P. J., Ciavarella, A. B., Asafu-Adjaye, E. B., Ellison, C. D., Yu, L. X., & Hussain, A. S. (2007) · Clinical Research and Regulatory Affairs · doi:10.1080/10601330701273669 · Cited by 94
Self-citationHanke, U., May, K. E., Rozehnal, V., Nagel, S., Siegmund, W., & Weitschies, W. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.008 · Cited by 94
Lin, X., Skolnik, S. M., Chen, X., & Wang, J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.034629 · Cited by 91
Castillo‐Garit, J. A., Marrero‐Ponce, Y., Torrens, F., & García‐Domenech, R. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21122 · Cited by 86
Kowapradit, J., Opanasopit, P., Ngawhirunpat, T., Apirakaramwong, A., Rojanarata, T., Ruktanonchai, U., & Sajomsang, W. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9399-7 · Cited by 84
Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents
Ranaldi, G., Islam, K., & Sambuy, Y. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.7.1374 · Cited by 83
Application and limitation of inhibitors in drug–transporter interactions studies
Wang, Q., Strab, R., Kardos, P., Ferguson, C., Li, J., Owen, A. J., & Hidalgo, I. J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.024 · Cited by 82
Fraction of a dose absorbed estimation for structurally diverse low solubility compounds
Sugano, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.049 · Cited by 75
Permeability classification of representative fluoroquinolones by a cell culture method
Volpe, D. A. (2004) · AAPS PharmSci · doi:10.1208/ps060213 · Cited by 73
Self-citationComprehensive Assessment of ADMET Risks in Drug Discovery
Wang, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682514 · Cited by 70
Paixão, P. J. P. A., Gouveia, L. F., & Morais, J. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.014 · Cited by 63
Cook, J., Feng, B., Fenner, K. S., Kempshall, S., Liu, R., Rotter, C. J., Smith, D. A., Troutman, M. D., Ullah, M., & Lee, C. A. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900174z · Cited by 61
Inhibition of P-glycoprotein–Mediated Efflux of Digoxin and Its Metabolites by Macrolide Antibiotics
Hughes, J., & Crowe, A. P. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10109fp · Cited by 60
Comparison of in vitro cell models in predicting in vivo brain entry of drugs
Hakkarainen, J. J., Jalkanen, A. J., Kääriäinen, T. M., Keski‐Rahkonen, P., Venäläinen, T., Hokkanen, J., Mönkkönen, J., Suhonen, M., & Forsberg, M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.016 · Cited by 59
Ming, X., & Thakker, D. R. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.029 · Cited by 56
Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450
Zhu, S., Huang, R., Hong, M., Jiang, Y., Zhuohan, H., Liu, C., & Pei, Y. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.05.001 · Cited by 55
Masungi, C., Mensch, J., Dijck, A. V., Borremans, C., Willems, B., Mackie, C. E., Noppe, M., & Brewster, M. (2008) · Die Pharmazie · doi:10.31083/ph.2008.7327 · Cited by 52
Kapitza, S. B., Michel, B. R., van Hoogevest, P., Leigh, M. L. S., & Imanidis, G. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.08.010 · Cited by 52
Effects of capsaicin on P-gp function and expression in Caco-2 cells
Han, Y., Tan, T. M. C., & Lim, L. Y. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.024 · Cited by 51
A 96-Well Efflux Assay To Identify ABCG2 Substrates Using a Stably Transfected MDCK II Cell Line
Xiao, Y., Davidson, R. E., Smith, A., Pereira, D. A., Zhao, S. X., Soglia, J. R., Gebhard, D. F., de Morais, S., & Duignan, D. B. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050088t · Cited by 48
Putnam, W. S., Ramanathan, S., Pan, L., Takahashi, L. H., & Benet, L. Z. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10264 · Cited by 48
Yan, Z., Sun, J., Chang, Y., Liu, Y., Fu, Q., Xu, Y., Sun, Y., Pu, X., Zhang, Y., Jing, Y., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100376q · Cited by 47
Tsume, Y., Vig, B. S., Sun, J., Landowski, C. P., Hilfinger, J. M., Ramachandran, C., & Amidon, G. L. (2008) · Molecules · doi:10.3390/molecules13071441 · Cited by 45
P-gp Inhibition Potential in Cell-Based Models: Which “Calculation” Method is the Most Accurate?
Balimane, P. V., Marino, A., & Chong, S. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9068-x · Cited by 45
Functional expression of novel peptide transporter in renal basolateral membranes
Terada, T., Sawada, K., Ito, T., Saito, H., Hashimoto, Y., & Inui, K. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.5.f851 · Cited by 44
Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers
Brayden, D. J., & Griffin, J. (2007) · Veterinary Research Communications · doi:10.1007/s11259-007-9007-9 · Cited by 43
In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules
Parmentier, J., Hartmann, F. J., & Fricker, G. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.09.002 · Cited by 41
Collett, A., Tanianis-Hughes, J., Carlson, G., Harwood, M. D., & Warhurst, G. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.07.013 · Cited by 41
Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system
Förster, F., Volz, A., & Fricker, G. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.10.003 · Cited by 39
Rais, R., Fletcher, S., & Polli, J. E. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22332 · Cited by 39
Interaction of gatifloxacin with efflux transporters: A possible mechanism for drug resistance
Kwatra, D., Vadlapatla, R. K., Vadlapudi, A. D., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.027 · Cited by 37
Lam, W. K., Felmlee, M. A., & Morris, M. E. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030775 · Cited by 35
Assessment of Macrolide Transport Using PAMPA, Caco-2 and MDCKII-hMDR1 Assays
Nožinić, D., Milić, A., Mikac, L., Ralić, J., Padovan, J., & Antolović, R. (2010) · University of Zagreb University Computing Centre (SRCE) · Cited by 31
Synthesis and in vitro evaluation of potential sustained release prodrugs via targeting ASBT
Zheng, X., & Polli, J. E. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.039 · Cited by 28
A Caco-2 cell based screening method for compounds interacting with MRP2 efflux protein
Siissalo, S., Hannukainen, J., Kolehmainen, J., Hirvonen, J. J., & Kaukonen, A. M. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.010 · Cited by 27
Mechanisms for membrane transport of metformin in human intestinal epithelial Caco-2 cells
Horie, A., Sakata, J., Nishimura, M., Ishida, K., Taguchi, M., & Hashimoto, Y. (2011) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.755 · Cited by 25
Berginc, K., Žakelj, S., & Kristl, A. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0095-x · Cited by 24
Caco‐2 and Emerging Alternatives for Prediction of Intestinal Drug Transport: A General Overview
Artursson, P., & Tavelin, S. (2003) · Methods and principles in medicinal chemistry · doi:10.1002/3527601473.ch4 · Cited by 23
Balimane, P. V., Chong, S., Patel, K., Quan, Y., Timoszyk, J. K., Han, Y., Wang, B., Vig, B. S., & Faria, T. N. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02980227 · Cited by 21
Evaluation of Drug Transporter Interactions in Drug Discovery and Development
Lai, Y., Sampson, K. E., & Stevens, J. C. (2010) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620710790596772 · Cited by 21
Hunter, J., Hirst, B. H., & Simmons, N. L. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90069-2 · Cited by 20
Mitigating permeability-mediated risks in drug discovery
Wang, J., & Skolnik, S. M. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903436486 · Cited by 20
Shin, H. J., Lee, C. H., Park, S., Shin, J., & Song, I. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0510-0 · Cited by 9
Cited by
Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040883 · Cited by 531
Orally Absorbed Cyclic Peptides
Nielsen, D. S., Shepherd, N. E., Xu, W., Lucke, A. J., Stoermer, M. J., & Fairlie, D. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00838 · Cited by 445
In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development
Brouwer, K. L. R., Keppler, D., Hoffmaster, K. A., Bow, D. A. J., Cheng, Y., Lai, Y., Palm, J. E., Stieger, B., & Evers, R. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.81 · Cited by 267
Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro
Keemink, J., Mårtensson, E., & Bergström, C. A. S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00811 · Cited by 82
Alternative methods to animal testing for the safety evaluation of cosmetic ingredients: an overview
Vinardell, M., & Mitjans, M. (2017) · Cosmetics · doi:10.3390/cosmetics4030030 · Cited by 37
Metadata
- Authors
- Volpe, D. A.
- Venue
- Future Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2011-11-18
- Volume
- 3
- Issue
- 16
- Pages
- 2063-2077
- ISSN
- 1756-8919 (ISSN-L)
- 1756-8927
- OpenAlex
- W2133464603
- Cited by
- 252
- References
- 80
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.